Profile picture

Doctor Per Ladenvall

AstraZeneca, Gothenburg (Sweden)
Follow
Logo ESC

Contributor content

Stroke risk in low-risk patients with atrial fibrillation on oral anticoagulation therapy: Insights from a Swedish cohort
Journal
Stroke risk in low-risk patients with atrial fibrillation on oral anticoagulation therapy: Insights from a Swedish cohort
5 November 2025
See more
Cancer as independent risk factor for ischemic stroke in low-risk patients with atrial fibrillation: Swedish national cohort study
Journal
Cancer as independent risk factor for ischemic stroke in low-risk patients with atrial fibrillation: Swedish national cohort study
5 November 2025
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources